Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Net Income Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual net income in 2023 was -1.1 Billion JPY , down -40.34% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly net income in 2024 Q1 was -219 Million JPY , down -6.96% from previous quarter.
  • Perseus Proteomics Inc. reported an annual net income of -786.99 Million JPY in 2022, down -31.38% from previous year.
  • Perseus Proteomics Inc. reported an annual net income of -599.02 Million JPY in 2021, down -44.97% from previous year.
  • Perseus Proteomics Inc. reported a quarterly net income of -211.36 Million JPY for 2023 Q2, up 49.93% from previous quarter.
  • Perseus Proteomics Inc. reported a quarterly net income of -422.12 Million JPY for 2023 Q1, down -87.82% from previous quarter.

Annual Net Income Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Net Income of Perseus Proteomics Inc. (2023 - 2019)

Year Net Income Net Income Growth
2023 -1.1 Billion JPY -40.34%
2022 -786.99 Million JPY -31.38%
2021 -599.02 Million JPY -44.97%
2020 -413.21 Million JPY 50.87%
2019 -841 Million JPY 0.0%

Peer Net Income Comparison of Perseus Proteomics Inc.

Name Net Income Net Income Difference
Kyowa Kirin Co., Ltd. 81.18 Billion JPY 101.36%
Astellas Pharma Inc. 17.04 Billion JPY 106.48%
Chugai Pharmaceutical Co., Ltd. 325.47 Billion JPY 100.339%
Ono Pharmaceutical Co., Ltd. 127.97 Billion JPY 100.863%
Santen Pharmaceutical Co., Ltd. 26.64 Billion JPY 104.146%
JCR Pharmaceuticals Co., Ltd. 5.5 Billion JPY 120.056%
Daiichi Sankyo Company, Limited 200.73 Billion JPY 100.55%
Otsuka Holdings Co., Ltd. 121.61 Billion JPY 100.908%